NASH - Nonalcoholic Steatohepatitis Completed Phase 1 Trials for Fluconazole (DB00196)

IndicationStatusPhase
DBCOND0088313 (NASH - Nonalcoholic Steatohepatitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03610945Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy VolunteersBasic Science